Nkarta (NKTX) Equity Ratio (2019 - 2026)
Nkarta's quarterly Equity Ratio came in at 0.77 in Q1 2026, down 4.55% year-on-year from 0.8 in Q1 2025, and down 0.57% quarter-over-quarter from 0.77 in Q4 2025.
Nkarta has reported Equity Ratio for 8 years, with the latest figure at 0.77 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 4.55% year-over-year to 0.77; the trailing twelve-month figure through Mar 2026 stood at 0.77 (down 4.55% YoY), and the FY2025 full-year result was 0.77, down 5.08% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.77, down from 0.77 in the prior quarter.
- The five-year high for Equity Ratio was 0.84 in Q2 2022, with the low at 0.72 in Q4 2023.
- Average Equity Ratio over 5 years is 0.78, with a median of 0.79 recorded in 2025.
- Year-over-year, Equity Ratio decreased 20.52% in 2022 and grew 12.85% in 2024.
- Tracing NKTX's Equity Ratio over 5 years: stood at 0.79 in 2022, then retreated by 8.35% to 0.72 in 2023, then grew by 12.85% to 0.81 in 2024, then declined by 5.08% to 0.77 in 2025, then fell by 0.57% to 0.77 in 2026.
- The last three Equity Ratio figures came in at 0.77 (Q1 2026), 0.77 (Q4 2025), and 0.79 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 0.04 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 0.42 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 0.73 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.77 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 0.21 |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - | 0.77 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.77 |
| Dec 31, 2025 | 0.77 |
| Sep 30, 2025 | 0.79 |
| Jun 30, 2025 | 0.80 |
| Mar 31, 2025 | 0.80 |
| Dec 31, 2024 | 0.81 |
| Sep 30, 2024 | 0.81 |
| Jun 30, 2024 | 0.82 |
| Mar 31, 2024 | 0.82 |
| Dec 31, 2023 | 0.72 |
| Sep 30, 2023 | 0.73 |
| Jun 30, 2023 | 0.74 |
| Mar 31, 2023 | 0.76 |
| Dec 31, 2022 | 0.79 |
| Sep 30, 2022 | 0.79 |
| Jun 30, 2022 | 0.84 |
| Mar 31, 2022 | 0.75 |
| Dec 31, 2021 | 0.92 |
| Sep 30, 2021 | 0.92 |
| Jun 30, 2021 | 0.93 |
| Mar 31, 2021 | 0.94 |
| Dec 31, 2020 | 0.95 |
| Sep 30, 2020 | 0.95 |
| Jun 30, 2020 | -1.92 |
| Dec 31, 2019 | -0.53 |